Maatje A. Van Gastel
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Defining patients living long-term with incurable cancer: A modified hybrid Delphi study.
Journal: Palliative medicine
Published: December 26, 2025
Sex-Specific Determinants of the Ketone Body β-Hydroxybutyrate in the General Population.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 03, 2025
Risk management with regard to QT-prolonging drugs
Journal: Nederlands tijdschrift voor geneeskunde
Published: June 18, 2024
Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: September 15, 2023
Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD.
Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 26, 2023
Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography - high speed and accuracy.
Journal: European radiology
Published: June 15, 2022
Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
Journal: Kidney360
Published: May 02, 2022
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: August 31, 2021
To Add Weight to Overweight.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: March 25, 2021
Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
Journal: Drugs in R&D
Published: March 10, 2021
The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study.
Journal: Clinical kidney journal
Published: November 30, 2020
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.
Journal: JAMA
Published: November 14, 2018
Last Updated: 09/26/2026